Literature DB >> 31792680

The Structure and Classification of Botulinum Toxins.

Min Dong1,2,3, Pål Stenmark4,5.   

Abstract

Botulinum neurotoxins (BoNTs) are a family of bacterial protein toxins produced by various Clostridium species. They are traditionally classified into seven major serotypes (BoNT/A-G). Recent progress in sequencing microbial genomes has led to an ever-growing number of subtypes, chimeric toxins, BoNT-like toxins, and remotely related BoNT homologs, constituting an expanding BoNT superfamily. Recent structural studies of BoNTs, BoNT progenitor toxin complexes, tetanus neurotoxin (TeNT), toxin-receptor complexes, and toxin-substrate complexes have provided mechanistic understandings of toxin functions and the molecular basis for their variations. The growing BoNT superfamily of toxins present a natural repertoire that can be explored to develop novel therapeutic toxins, and the structural understanding of their variations provides a knowledge basis for engineering toxins to improve therapeutic efficacy and expand their clinical applications.

Entities:  

Keywords:  Bacterial toxins; BoNT; BoNT-like toxins; Botox; Botulinum neurotoxin; Botulinum toxin; Tetanus neurotoxin; X-ray crystal structure

Year:  2021        PMID: 31792680     DOI: 10.1007/164_2019_342

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  99 in total

1.  Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

Authors:  Joseph W Arndt; Wayne Yu; Fay Bi; Raymond C Stevens
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

2.  Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.

Authors:  Joseph W Arndt; Qing Chai; Todd Christian; Raymond C Stevens
Journal:  Biochemistry       Date:  2006-03-14       Impact factor: 3.162

3.  Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex.

Authors:  Sho Amatsu; Yo Sugawara; Takuhiro Matsumura; Kengo Kitadokoro; Yukako Fujinaga
Journal:  J Biol Chem       Date:  2013-10-28       Impact factor: 5.157

4.  Unique ganglioside recognition strategies for clostridial neurotoxins.

Authors:  Marc A Benson; Zhuji Fu; Jung-Ja P Kim; Michael R Baldwin
Journal:  J Biol Chem       Date:  2011-08-17       Impact factor: 5.157

5.  Long-distance retrograde effects of botulinum neurotoxin A.

Authors:  Flavia Antonucci; Chiara Rossi; Laura Gianfranceschi; Ornella Rossetto; Matteo Caleo
Journal:  J Neurosci       Date:  2008-04-02       Impact factor: 6.167

6.  A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.

Authors:  Jason R Barash; Stephen S Arnon
Journal:  J Infect Dis       Date:  2013-10-07       Impact factor: 5.226

7.  Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.

Authors:  Rakhi Agarwal; James J Schmidt; Robert G Stafford; Subramanyam Swaminathan
Journal:  Nat Struct Mol Biol       Date:  2009-06-21       Impact factor: 15.369

8.  Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A.

Authors:  Roger M Benoit; Daniel Frey; Manuel Hilbert; Josta T Kevenaar; Mara M Wieser; Christian U Stirnimann; David McMillan; Tom Ceska; Florence Lebon; Rolf Jaussi; Michel O Steinmetz; Gebhard F X Schertler; Casper C Hoogenraad; Guido Capitani; Richard A Kammerer
Journal:  Nature       Date:  2013-11-17       Impact factor: 49.962

9.  Structure of dual receptor binding to botulinum neurotoxin B.

Authors:  Ronnie P-A Berntsson; Lisheng Peng; Min Dong; Pål Stenmark
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Crystal structure of the BoNT/A2 receptor-binding domain in complex with the luminal domain of its neuronal receptor SV2C.

Authors:  Roger M Benoit; Martin A Schärer; Mara M Wieser; Xiaodan Li; Daniel Frey; Richard A Kammerer
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

View more
  7 in total

Review 1.  Regulatory Networks Controlling Neurotoxin Synthesis in Clostridium botulinum and Clostridium tetani.

Authors:  Michel R Popoff; Holger Brüggemann
Journal:  Toxins (Basel)       Date:  2022-05-24       Impact factor: 5.075

Review 2.  Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.

Authors:  Dominick A Centurioni; Christina T Egan; Michael J Perry
Journal:  J Clin Microbiol       Date:  2021-09-29       Impact factor: 11.677

Review 3.  Human Botulism in France, 1875-2016.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-05-21       Impact factor: 4.546

Review 4.  Adult Intestinal Toxemia Botulism.

Authors:  Richard A Harris; Fabrizio Anniballi; John W Austin
Journal:  Toxins (Basel)       Date:  2020-01-24       Impact factor: 4.546

5.  Targeted intracellular delivery of Cas13 and Cas9 nucleases using bacterial toxin-based platforms.

Authors:  Songhai Tian; Yang Liu; Evan Appleton; Huan Wang; George M Church; Min Dong
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.423

Review 6.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

7.  BOTOX injection to treat strabismus after infant botulism type B infection.

Authors:  Sarah G Bonaffini; Victoria Cocozza; Jing Jin
Journal:  Am J Ophthalmol Case Rep       Date:  2020-08-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.